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Background: Bovine leukemia virus (BLV) is worldwide distributed and highly endemic in Argentina. Among the
strategies to prevent BLV dissemination, a control plan based on the selective segregation of animals according to
their proviral load (PVL) is promising for our dairy productive system. The objective of this work was to study the
relationship between the blood PVL and the antibody level, in order to identify whether the individual humoral
response, i.e. the anti-p24 or anti-whole-BLV particle, could be used as a marker of the blood level of infection and
thus help to recruit animals that may pose a lower risk of dissemination under natural conditions.
Results: The prevalence of p24 antibodies on the 15 farms studied was over 66%. The prevalence of p24 and
whole-BLV antibodies and PVL quantification were analyzed in all the samples (n = 196) taken from herds T1 and 51.
ROC analysis showed a higher AUC for p24 antibodies than whole-BLV antibodies (Zreactivity: 3.55, P< 0.001; Ztiter:
2.88, P< 0.01), and as consequence a better performance to predict the proviral load status in herd 51. No
significant differences were found between the performance of p24 and whole-BLV antibodies in herd T1. A
significant positive correlation was observed between PVL values and p24 antibody reactivity in both farms (r
T1 = 0.7, P< 0.001, r 51 = 0.71, P< 0.0001). The analysis was extended to the whole number of weak p24 antibody
reactors (n = 311) of the other 13 farms. The mean of high PVL reactors within weak p24 reactors was 17.38%
(SD= 8.92). In 5/15 farms, the number of weak p24 reactors with high PVL was lower than 10%.
Conclusions: We found that the humoral response reflected the level of in vivo infection, and may therefore have
useful epidemiological applications. Whereas the quantitative evaluation of blood proviral load using real-time PCR
is expensive and technically demanding, the measurement of antibodies in blood by ELISA is relatively
straightforward and could therefore constitute a cost-effective tool in a BLV control intervention strategy, especially
in highly infected herds such as Argentinean dairy ones.
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Bovine leukemia virus (BLV), the causative agent of adult
B-cell lymphosarcoma, is worldwide distributed and
highly endemic in Argentina [1]. Considering the high
individual prevalence on dairy farms and the absence of
an official compensation policy, the application of clas-
sical control measures based on the elimination of
infected cattle makes it a cost-prohibitive option. Among* Correspondence: ggutierrez@cnia.inta.gov.ar
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reproduction in any medium, provided the orthe strategies to prevent BLV dissemination [2], a con-
trol plan based on the selective segregation of animals
according to their proviral load (PVL) is promising for
our dairy productive system [3,4].
Previous studies have shown that, under experimental
conditions, animals with high levels of in vivo infection
are the most contagious ones [5]. Under field conditions,
these animals could be detected and eliminated with the
aim to reduce the transmission of the virus to suscep-
tible animals. The objective of this work was to study
the relationship between the blood PVL and the anti-
body level, in order to identify whether the individual
humoral response, i.e. the anti-p24 or anti-whole-BLVal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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infection and thus help to recruit animals that may pose
a lower risk of dissemination under natural conditions.
Methods
Farms and samples under study
A cross-sectional study was carried out using blood sam-
ples from 15 commercial dairy farms highly infected
with BLV (Table 1). One of the dairy farms raised Jersey
cows (T1) whereas the remaining 14 raised Holstein
cows. Samples were brought to the laboratory for BLV
serology and PVL quantification because these farms are
enrolled in a project that aims to analyze genetic poly-
morphisms related to BLV infection in the complete host
genome. All lactating cattle with traceable progenitors
and three or more deliveries were selected and sampled.
The number of samples collected on each farm for the
analysis of seroprevalence and PVL is shown in Table 1.
Blood was taken by jugular venipuncture with and with-
out heparin. Serum and whole blood was stocked frozen
until analyzed. The procedures followed for extraction
and handling of samples were approved by the Institu-
tional Committee for Care and Use of Experimental
Animals of the National Institute of Agricultural Tech-
nology (CICUAE-INTA) under protocol number 35/
2010 and followed the guidelines described in the insti-
tutional Manual.
BLV serology
Two in-house developed ELISA tests, using a total lysate
of the BLV virus and a recombinant BLV-p24 viral coreTable 1 Farms and samples under study: Seroprevalence in d
Herd
ID
Animals in farm* Samples under study
n n %
51 299 146 48.8
52 203 90 44.3
53 280 81 28.9
57 142 57 40.1
58 293 157 53.5
60 332 140 42.1
61 235 92 39.1
62 384 166 43.2
63 277 137 49.4
64 503 186 36.9
67 247 127 51.4
70 273 111 40.6
71 184 112 60.8
72 241 100 41.4
T1 250 50 20.0
*total lactating, **p24 antibodies, *** Reactivity 25-99%, % among total p24 reactorprotein, designated in this study as whole-BLV ELISA
and p24 ELISA, respectively, were used to detect BLV
antibodies [1,6]. Normalized results were obtained as a
sample to positive (S/P) ratio, and designated as reactiv-
ity. A weak positive control serum was used to calculate
the ratio. Its reactivity was set to 100% and all samples
were referred to it. The cut-off point was set up at 25%
according to that previously described for both tests
[1,6]. Depending on their reactivity, samples were stated
as negative (<25), weak (25-99.99%) or strong (≥100%).
The antibody titers were assayed by the end-point dilu-
tion method using two-fold dilutions of sera.
DNA extraction and PCR amplification
Total DNA was extracted from frozen whole blood using
a DNA extraction kit (High Pure PCR Template Prepar-
ation kit, Roche, Penzberg, Germany) according to the
manufacturer’s instructions. The relative quantification
of PVL was assessed by Taq Man real-time PCR [3]. All
samples were tested in duplicate by using 50 ng of DNA
as template. A fragment of the BLV pol gene [7] was
amplified together with a fragment of the constitutive
18 S gene [7], used as reference. As an internal control
sample for both the BLV target gene and the 18 S refer-
ence gene, we used 50 ng of DNA from fetal lamb kid-
ney (FLK) cells, containing four copies of BLV proviral
DNA per cell, in a final concentration of 1% in periph-
eral blood mononuclear cells (PBMCs) purified from a
non-infected cow. The relative PVL was expressed as the
ratio obtained by the sample for the BLV gene in com-
parison to the 18 S reference gene, based on theifferent herds
Seroprevalence** Weak p24 Reactors ***
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ternal control sample [8]. With this method, the relative
PVL of the control sample was set to 1 and all samples
were referred to it. The reaction showed a limit of detec-
tion of 1 BLV-infected cell in 2000 non-infected cells, as
previously reported [3]. The PVL was stated as undetect-
able if no cycle threshold value was obtained from the
BLV pol specific reaction, low if the ratio obtained was
lower than 1, and high if the ratio obtained was equal to
or higher than 1. The level of BLV-infected/non-infected
cells in the internal control was set up considering that
the low PVL group should include only aleukemic ani-
mals, since the maximum level of provirus at this stage
of infection can reach 5% of BLV-infected/non-infected
cells, according to published data [9].
Statistical analysis
The antibody levels from different PVL groups were
compared by the Kruskall Wallis test. Receiver operator
characteristic (ROC) curves were constructed to evaluate
the potential of antibodies to discriminate between ani-
mals with high or low/undetectable PVL. In this analysis,
the level of in vivo infection or PVL was considered as
the reference status and only two categories were con-
sidered: high and undetectable/low. Sensitivity was defined
as the proportion of animals with high PVL which were
correctly identified, whereas specificity was defined as the
proportion of animals with undetectable/low PVL, compat-
ible with the aleukemic stage, which were correctly identi-
fied. The Spearman rank test was used to analyze the
correlation between PVL and p24 antibody levels. For all
the analyses, a value of P<0.05 was considered significant.
All data were analyzed with GraphPad Prism for Windows
v. 5.01. MedCalc v. 12.3.0.0 was used to compare areas
under the ROC curve statistically.
Results
The prevalence of p24 antibodies on the 15 farms stud-
ied was over 66% (Table 1). The prevalence of whole-
BLV antibodies and PVL quantification were analyzed in
all the samples (n = 196) taken from herds T1 and 51
(Table 2). In both herds, whole-BLV antibodies were
detected in a greater proportion of animals than p24
antibodies (Table 2). More than 20% of the p24 seroreac-










T1 66.0 82.0 21.2 45.5 33.3
51 87.7 100.0 32.0 24.2 43.8
All numbers are percentages. pos) positive, PVL) proviral load, U) undetectable,
L) low, H) high.showed low PVL (Table 2), being both categories com-
patible with the aleukemic infection stage. The rate of
animals with high PVL among p24 seroreactors and
hence, with more than 1% BLV-infected PBMCs, was
33.3% on farm T1 and 43.8% on farm 51. All the animals
stated as positive to whole-BLV antibodies and negative
to p24 antibodies from both farms (n = 21) showed un-
detectable (20/21) or low (1/21) PVL (data not shown).
ROC analysis showed a higher AUC for p24 antibodies
than whole-BLV antibodies (Zreactivity: 3.55, P < 0.001;
Ztiter: 2.88, P < 0.01), and as consequence a better per-
formance to predict the proviral load status in herd 51
(Figure 1.a). No significant differences were found be-
tween the performance of p24 and whole-BLV antibodies
in herd T1 (Zreactivity: 0.26, P= 0.79; Ztiter: 0.09, P= 0.93)
(Figure 1.b). Both, the p24 reactivity and titer showed
similar AUC values and resulted in a similar estimation
of sensitivity and specificity (Figure 1). The p24-antibody
reactivity from animals with high PVL was significantly
higher than those from animals with low and undetect-
able PVL (Figure 2) in both herds.
A significant positive correlation was observed be-
tween PVL values and p24 antibody reactivity in both
farms (r T1 = 0.7, P < 0.001, r 51 = 0.71, P < 0.0001), where
the rate of animals with high PVL increased in concord-
ance with the antibody category, and varied from 8.3 to
13% in weak reactors and from 47.6 to 61% in strong
ones (Figure 3). According to the above findings that
showed that a weak p24 antibody reactivity could be a
good indicator of low PVL, the analysis was extended to
the whole number of weak p24 antibody reactors
(n = 311) of the other 13 farms, where 12.5% to 31.1% of
all the seroreactors showed weak reactivity (Mean =
21.23, SD= 5.44) (Table 1). Figure 4 shows the distribu-
tion of PVL in the weak p24 antibody reactors from the
different farms. The mean of high PVL reactors within
this group was 17.38% (SD= 8.92). In 5/15 farms, the
number of high PVL animals was lower than 10%. The
highest proportion of high PVL animals was 33.3% on
Farm 61, which showed 22.9% of the animals within the
weak p24 subgroup (Table 1).
Discussion
In this study, we analyzed the PVL and the antibody
level of naturally BLV-infected cattle from fifteen differ-
ent herds. We found that the humoral response reflected
the level of in vivo infection, and may therefore have
useful epidemiological applications.
We worked with 15 commercial herds, which are typical
large dairy herds of the country considering productive
parameters and BLV prevalence (Table 1). This study com-
plements an ongoing work, in which the same animals are
being studied for the presence of polymorphisms in the
Figure 1 ROC curve analysis for BLV antibody reactivities and titers to predict the blood PVL in the two herds under study: a) 51, b)
T1. For this analysis, the PVL was divided into two groups: high and low/undetectable. Ab) antibody.
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PVL outcome.
In all farms, we found animals with different PVL sta-
tus (Figure 4), which confirmed the concept that BLV
PVL varies between naturally infected animals, as previ-
ously reported in two previous works, both based on
one farm case [3,4].
The results presented here provide a baseline to design
an alternative control strategy based on the permanence
of animals with low levels of infection in the herd, follow-
ing the hypothesis that the level of proviral BLV in blood
should play a major role in the success or failure of BLV
transmission, as reported for experimental BLV infec-
tions [5,10] and natural Human T Lymphotropic Virus-1
(HTLV-1) infections [11]. The main goal of this program
would be the rational control of intentional virus propa-
gation, with the aim to obtain a low PVL in the wholeFigure 2 p24 antibody reactivity descriptive analysis in different PVL
cows depending on their PVL category in herds: a) 51 and b) T1. U) undec
Wallis test was used to evaluate differences between categories, P values aherd, to finally diminish the risk of animal-to-animal
transmission.
Under a practical point of view, the elimination of all
infected animals with high proviral load is not be feasible
on individual farms, since apart from mortality due to spor-
adic cases of lymphosarcoma, productive parameters are
considered as normal in this group of cattle. In this context,
the application of a selective segregation plan based on pro-
viral load could be appropriate in a consortium-based strat-
egy, where a group of farms work together toward the
elimination of infection. In this case, animals with low pro-
viral load should be recruited to form a low-transmission
farm. In this scenario, the quantification using real-time
PCR in whole natural herds to select animals that would be
recruited to form the low-transmission farm would be ex-
tremely expensive. Hence, an alternative approach to select
and recruit clean and low-infected animals becomescategories. Box and whisker plots show p24 antibody reactivity of the
tectable, L) low and H) high proviral load, Ab) antibody. The Kruskal-
re shown.
Figure 3 Proviral load distribution in different p24 antibody categories. The frequencies of animals with different levels of proviral load are
shown for each p24 Ab category in herds: a) 51 and b) T1. U) undetectable, L) low and H) high proviral load, Ab) antibody.
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tionship between the individual level of infection and the
serological profile with the aim to find an affordable indica-
tor of PVL that could be used in local laboratories without
the need of expensive equipment and reagents. We first
analyzed whole-BLV and p24 antibodies in two herds, in
which we quantified PVL in the total number of samples,
with the aim to detect the best PVL predictor among the
serological options. The ROC analysis showed that p24
antibodies allow predicting the PVL with a similar perform-
ance when titer or reactivity values are used for calculation
(Figure 1). Even when whole-BLV antibodies were detected
in a greater proportion of animals, we found no evident
reason to work with these antibodies; as all these animals
showed undetectable or low PVL. In our situation, this is
important for two reasons. First, although the two ELISAFigure 4 Proviral load distribution in weak p24 antibody reactivity an
selected from 15 herds and analyzed for BLV proviral load. The percen
load are shown. Ab) antibody.antigens used were in-house, the p24-ELISA uses an
Escherichia coli recombinant-derived antigen, which is less
expensive and laborious to elaborate than the cell-derived
antigen used in the whole-BLV ELISA. Secondly, there is
no need to titrate the samples, since the strength of ELISA
reactions seems to be as good as titer to predict the PVL
(Figure 1). These two reasons make the serological analysis
extremely cheap and straightforward. The prediction made
by ROC analysis in these two farms was supported by the
analysis of variance (Figure 2) and the correlation analysis,
which showed that PVL is well reflected by the p24 anti-
body level.
Since the analysis of p24 antibodies showed a subpopu-
lation of weak-p24 reactors in all herds (Table 1), we
extended the analysis of PVL to this subgroup. We con-
firmed that a great proportion of animals of this subgroupimals from 15 dairy herds. p24 seropositive animals were
tages of animals with undetectable/low (U/L) and high (H) proviral
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allows us to consider this subpopulation as a good candi-
date to be recruited as potentially low disseminators of
infection. In a consortium-based approach, at least 20%
of the animals of each farm should be considered as puta-
tive donors to form a BLV low-dissemination herd
according to our analysis (Table 1).
Then, the control strategy would consist in the recruit-
ment of animals with low or undetectable PVL using p24
serology as a low-cost method, instead of PVL quantifica-
tion. This plan should be rationally designed considering
that (1) all the animals that participate in the plan should
be checked for p24 antibody reactivity, (2) negative and
weak p24 reactors should be selected and recruited to
form a new potentially low-transmission farm, (3) PVL
should be checked up in the recruited group, in which ani-
mals with high PVL will still be present and should be
eliminated, and (4) monitoring should be done in a regular
basis to constantly “clean” high PVL individuals that might
appear, even when PVL is thought to keep constant [12].
With this strategy, the transmission rate should become
lower and lower as the animals with high propagation po-
tential are removed.
A risk assessment should be made to analyze the dy-
namics of infection under these conditions, especially con-
sidering the theoretical extinction time when compared
with naturally infected farms, as previously discussed [13].
Although this kind of control program based on the
in vivo level of infection has been proposed [4], there are
no reports showing the application and/or success of
this strategy. In this context, a field trial will be designed
and set up to analyze the feasibility and risk of the strat-
egy, as a rational alternative to control BLV infection.
Finally, whether or not the immune response only
reflects or also controls PVL is still unknown. Further
studies should be carried out to define the reasons of
the individual PVL differences and whether they are
caused by the host genetic background, the viral strain,
the infectious dose, and/or are due to multifactorial rea-
sons. In the context of HTLV infection, the PVL is also
correlated with the level of circulating antibodies [14,15]
and the specific CD8+ lymphocyte response contributes
to the control of the PVL and is associated with a lower
risk of clinical disease progression [16]. Similar phenom-
ena could be occurring with BLV natural infection and
studies regarding the BLV-specific cytotoxic response
and its relationship with the PVL and the humoral anti-
body response would be appropriate.
Conclusion
Our investigation represents the first study showing that
the level of BLV-specific antibodies reflects the circulating
proviral load. Whereas the quantitative evaluation of
blood proviral load using real-time PCR is expensive andtechnically demanding, the measurement of antibodies in
blood by ELISA is relatively straightforward and could
therefore constitute a cost-effective tool in a BLV control
intervention strategy, especially in highly infected herds
such as Argentinean dairy ones.
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